Internal Medicine, Rheumatology · Santa Clarita, CA
NPI
1871695346
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
21060 Centre Pointe Pkwy
Santa Clarita, CA, 91350
Phone (661) 254-1202
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
66,085 services
Medicare patients, 2024
305
Average age 71
Drug cost, 2024
$3.1M
3,168 prescriptions
Company payments, 2025
$2,556
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yoon S Min was code J0897 (injection, denosumab, 1 mg), 6,000 times for 59 patients. In total Yoon S Min billed 66,085 services in 63 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,000 | 59 | $20.68 | $124K |
| J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 1,924 | 24 | $5.73 | $11K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,424 | 125 | $0.77 | $1,100 |
| 86235 Immunoassay | Office | 1,401 | 141 | $17.57 | $25K |
| 99214 Office E&M - Established | Office | 1,211 | 280 | $105.38 | $128K |
| J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 1,128 | 15 | $13.67 | $15K |
| 97032 PT Treatment | Office | 692 | 19 | $9.42 | $6,518 |
| 86147 Immunoassay | Office | 598 | 142 | $24.94 | $15K |
| 97112 PT Treatment | Office | 519 | 19 | $23.84 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 492 | 209 | $13.33 | $6,560 |
| 20611 Joint Injection | Office | 413 | 86 | $72.18 | $30K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 384 | 20 | $0.09 | $33.41 |
| 96401 Chemotherapy Administration | Office | 360 | 91 | $64.22 | $23K |
| 96413 Chemotherapy Administration | Office | 276 | 40 | $114.26 | $32K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 271 | 38 | $0.51 | $137 |
By year: 2022 $852K for 55,622 services; 2023 $781K for 46,671 services; 2024 $1.0M for 66,085 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 1,401 | 141 | $17.57 | $25K |
| 86147 Immunoassay | 598 | 142 | $24.94 | $15K |
| 83516 Immunoassay | 258 | 112 | $11.30 | $2,915 |
| 36415 Venipuncture Blood Collection | 230 | 147 | $8.65 | $1,990 |
| 86226 Immunoassay | 201 | 141 | $11.87 | $2,386 |
| 86225 Immunoassay | 201 | 141 | $13.47 | $2,707 |
| 86200 Immunoassay | 136 | 112 | $12.69 | $1,726 |
| 86431 Immunoassay | 132 | 112 | $5.56 | $734 |
| 86038 Immunoassay | 120 | 105 | $11.85 | $1,422 |
Medicare prescription drug claims, 2024
In 2024, the drug Yoon S Min prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 401 prescriptions and refills. In total Yoon S Min wrote 3,168 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 401 | 676 | 89 | $16K |
| Prednisone Generic | 193 | 255 | 58 | $1,369 |
| Methotrexate Methotrexate Sodium | 176 | 267 | 38 | $3,812 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 173 | 173 | 26 | $5,293 |
| Gabapentin Generic | 136 | 182 | 30 | $1,891 |
| Leflunomide Generic | 97 | 163 | 26 | $7,827 |
| Sodium Chloride 0.9 % Sodium Chloride | 86 | 94 | 14 | $184 |
| Orencia Abatacept/Maltose | 55 | 59 | Under 11 | $262K |
| Cyclobenzaprine Hcl Generic | 54 | 60 | 14 | $1,294 |
| Meloxicam Generic | 54 | 86 | 15 | $121 |
| Rinvoq Upadacitinib | 52 | 56 | Under 11 | $354K |
| Benlysta Belimumab | 51 | 51 | Under 11 | $195K |
| Ibuprofen Generic | 50 | 52 | 12 | $359 |
| Alendronate Sodium Generic | 47 | 72 | 11 | $226 |
| Diclofenac Sodium Generic | 46 | 62 | 20 | $2,437 |
Brand drugs: 626 claims; generic drugs: 2,542 claims; opioid claims: 357.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yoon S Min $2,556 ($2,556 in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $404.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $404 |
| ANI Pharmaceuticals, Inc. ANIP | 13 | $348 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $276 |
| Janssen Biotech, Inc. JNJ | 11 | $276 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $235 |
| UCB, Inc. UCB.BR | 7 | $159 |
| Abbvie Inc. ABBV | 6 | $154 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $142 |
| Sobi, Inc SOBI.ST | 4 | $136 |
| Mallinckrodt Hospital Products Inc. | 4 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.